Effect of antenatal dexamethasone therapy on maternal plasma human chorionic gonadotrophin, oestradiol and progesterone

• Published in: Human reproduction (Oxford) Vol. 14; no. 2; pp. 303 - 306
• Main Authors: Ogueh, O., Jones, J., Mitchell, H., Alaghband-Zadeh, J., Johnson, M.R.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.02.1999; Oxford Publishing Limited (England)
• Subjects: Adult; Biological and medical sciences; Chorionic Gonadotropin - blood; dexamethasone; Dexamethasone - therapeutic use; Estradiol - blood; Female; Glucocorticoids - therapeutic use; HCG; Hormones. Endocrine system; Humans; Longitudinal Studies; Medical sciences; oestradiol; Pharmacology. Drug treatments; Pregnancy - blood; Prenatal Care; progesterone; Progesterone - blood; dexamethasone; oestradiol; HCG; progesterone; Human; Corticosteroid; Dexamethasone; Steroid hormone; Antiinflammatory agent; Estrogen; Gonadotropin; Estradiol; Intramuscular administration; Ovarian hormone; Placental hormone; Blood plasma; Pregnancy; Prenatal; Human chorionic gonadotrophin; Progesterone; Sex steroid hormone; Woman
• ISSN: 0268-1161; 1460-2350
• DOI: 10.1093/humrep/14.2.303

The aim of this study was to determine whether the current regimen of dexamethasone administration to induce fetal lung maturation affected the circulating concentrations of placental hormone. A standard regimen of dexamethasone that comprised two doses of 12-mg intramuscular injections, 12 h apart was administered to 12 pregnant women to promote fetal lung maturation in anticipation of premature delivery before 34 completed weeks of gestation. Blood samples were collected before starting the dexamethasone therapy, 24 h, and 48 h after completing therapy for the measurement of the plasma concentrations of human chorionic gonadotrophin (HCG), oestradiol and progesterone. There was a progressive fall in the plasma concentrations of HCG following dexamethasone therapy (P = 0.049 and P = 0.034, 24-h and 48-h post therapy respectively). There was an initial fall in the plasma concentrations of oestradiol after dexamethasone therapy (z = 3.059; P = 0.002, 24-h post therapy), which recovered by 48 h (P = 0.239). There was no difference between the plasma concentrations of progesterone at the three time points. The effect of dexamethasone on HCG concentrations suggests that it has a direct inhibitory effect on placental hormone synthesis or secretion. Further studies are needed to define the mechanism of action of dexamethasone on placental HCG production.